[Effect of 0.1% dexamethasone and 1.0% prednisolone acetate eyedrops on the blood-aqueous humor barrier]
- PMID: 1304212
[Effect of 0.1% dexamethasone and 1.0% prednisolone acetate eyedrops on the blood-aqueous humor barrier]
Abstract
In a randomized, double-blind clinical trial we studied the protective effect of prednisolone-acetate 1.0% and dexamethasone 0.1% on the blood-aqueous barrier after cataract-extraction and posterior chamber lens implantation. Pre- and postoperative anterior chamber fluorophotometry was performed after i.v. administration of 10% fluorescein-sodium in 20 eyes of 20 patients of whom 16 finished the study (mean age 68.7 +/- 11.0; 13 female, 3 male). The topical application of either drug 5 times daily for 5 days did show a significant difference in surgery mediated disturbance of BAB in each group before and after phacoemulsification. However, when comparing the effect of the two drugs with each other, a difference could not be detected (p = 0.35). To attain a statistical 95% probability that there is no significant difference between the two treatment groups, a number of 690 patients would have had to be investigated. The results can be interpreted as to be due to a better cornea penetration of prednisolone-acetate which compensate the higher glucocorticoid-potency and receptor-affinity of dexamethasone. The untreated fellow-eyes did not reveal a significant difference between the pre- and postoperative anterior chamber fluorescein-concentrations in either treatment group. Anterior chamber fluorophotometry is able to demonstrate the potency and influence of both prednisolone-acetate 1.0% and dexamethasone 0.1% eye-drops on the BAB following phacoemulsification and IOL-implantation. The difference of both drugs does not seem to be of clinical importance in this context.
Similar articles
-
Effect of dexamethasone 0.1% and prednisolone acetate 1.0% eye drops on the blood-aqueous barrier after cataract surgery: a controlled randomized fluorophotometric study.Graefes Arch Clin Exp Ophthalmol. 1992;230(5):451-3. doi: 10.1007/BF00175932. Graefes Arch Clin Exp Ophthalmol. 1992. PMID: 1521812 Clinical Trial.
-
Randomized clinical trial of a new dexamethasone delivery system (Surodex) for treatment of post-cataract surgery inflammation.Ophthalmology. 1999 Feb;106(2):223-31. doi: 10.1016/S0161-6420(99)90060-X. Ophthalmology. 1999. PMID: 9951469 Clinical Trial.
-
[Influence of cataract and posterior chamber lens implantation on the dynamics of the aqueous humor. Prospective study in fluorophotometry].J Fr Ophtalmol. 1991;14(4):255-9. J Fr Ophtalmol. 1991. PMID: 1955653 French.
-
Reducing angiographic cystoid macular edema and blood-aqueous barrier disruption after small-incision phacoemulsification and foldable intraocular lens implantation: multicenter prospective randomized comparison of topical diclofenac 0.1% and betamethasone 0.1%.J Cataract Refract Surg. 2008 Jan;34(1):57-63. doi: 10.1016/j.jcrs.2007.08.030. J Cataract Refract Surg. 2008. PMID: 18165082 Clinical Trial.
-
[Effect of cataract extraction on aqueous humor dynamics in patients with senile cataract. A prospective fluorophotometric study].Fortschr Ophthalmol. 1991;88(2):128-31. Fortschr Ophthalmol. 1991. PMID: 1855728 German.
Cited by
-
The effect of argon laser trabeculoplasty on the blood-aqueous barrier and intraocular pressure in human glaucomatous eyes treated with diclofenac 0.1%.Graefes Arch Clin Exp Ophthalmol. 1995 Sep;233(9):559-62. doi: 10.1007/BF00404706. Graefes Arch Clin Exp Ophthalmol. 1995. PMID: 8543206 Clinical Trial.